GRCE
Price
$3.13
Change
-$0.09 (-2.80%)
Updated
Aug 11, 02:29 PM (EDT)
Capitalization
44.53M
VTYX
Price
$2.66
Change
-$0.15 (-5.34%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
199.96M
93 days until earnings call
Interact to see
Advertisement

GRCE vs VTYX

Header iconGRCE vs VTYX Comparison
Open Charts GRCE vs VTYXBanner chart's image
Grace Therapeutics
Price$3.13
Change-$0.09 (-2.80%)
Volume$1K
Capitalization44.53M
Ventyx Biosciences
Price$2.66
Change-$0.15 (-5.34%)
Volume$22.61K
Capitalization199.96M
GRCE vs VTYX Comparison Chart in %
Loading...
GRCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRCE vs. VTYX commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRCE is a Hold and VTYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (GRCE: $3.22 vs. VTYX: $2.81)
Brand notoriety: GRCE and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRCE: 264% vs. VTYX: 119%
Market capitalization -- GRCE: $44.53M vs. VTYX: $199.96M
GRCE [@Biotechnology] is valued at $44.53M. VTYX’s [@Biotechnology] market capitalization is $199.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRCE’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • GRCE’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, GRCE is a better buy in the long-term than VTYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRCE’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • GRCE’s TA Score: 5 bullish, 5 bearish.
  • VTYX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both GRCE and VTYX are a good buy in the short-term.

Price Growth

GRCE (@Biotechnology) experienced а +12.20% price change this week, while VTYX (@Biotechnology) price change was +6.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

VTYX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($200M) has a higher market cap than GRCE($44.5M). VTYX YTD gains are higher at: 28.310 vs. GRCE (-13.904). GRCE has higher annual earnings (EBITDA): -16.72M vs. VTYX (-135.48M). VTYX has more cash in the bank: 229M vs. GRCE (11.1M). GRCE (0) and VTYX (0) have equivalent revenues.
GRCEVTYXGRCE / VTYX
Capitalization44.5M200M22%
EBITDA-16.72M-135.48M12%
Gain YTD-13.90428.310-49%
P/E RatioN/AN/A-
Revenue00-
Total Cash11.1M229M5%
Total DebtN/A10.5M-
FUNDAMENTALS RATINGS
GRCE: Fundamental Ratings
GRCE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRCEVTYX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 22 days ago
79%
Bullish Trend 12 days ago
86%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
GRCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEVO1.180.03
+2.61%
Gevo
IONS41.640.59
+1.44%
Ionis Pharmaceuticals
ALEX18.210.04
+0.22%
Alexander & Baldwin
PBBK18.35-0.05
-0.27%
PB Bankshares
LLY625.65-15.21
-2.37%
Eli Lilly & Co

GRCE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRCE has been loosely correlated with SLNO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GRCE jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRCE
1D Price
Change %
GRCE100%
+9.15%
SLNO - GRCE
38%
Loosely correlated
+4.62%
CYTK - GRCE
37%
Loosely correlated
-3.23%
VTYX - GRCE
28%
Poorly correlated
+19.07%
ASMB - GRCE
28%
Poorly correlated
+12.96%
ARGX - GRCE
27%
Poorly correlated
-1.56%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+19.07%
KYMR - VTYX
49%
Loosely correlated
-0.56%
ADCT - VTYX
46%
Loosely correlated
+1.52%
SYRE - VTYX
45%
Loosely correlated
N/A
IMNM - VTYX
44%
Loosely correlated
-1.82%
OCUL - VTYX
44%
Loosely correlated
-0.73%
More